Resources » Resources Search » MPP: UPDATE ON PROGRESS OF MPP SUBLICENSEES

MPP: UPDATE ON PROGRESS OF MPP SUBLICENSEES

Here is a presentation highlighting the progress of MPP’s generic partners in developing MPP-licensed medicines. It provides an overview of manufacturer filing timelines per combination, countrywide filing status and plans for registration, as well as the latest impact data from MPP’s  agreements. Generic competition is making a difference in fostering lower prices and improving treatment coverage.

Access the presentation

This website uses cookies to ensure you get the best experience on our website. Learn More